**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: February 12, 1990
* Admission Date: March 10, 2023
* Discharge Date: March 15, 2023

**Chief Complaint:**

John Doe, a 33-year-old male, was admitted to the infectious diseases unit on March 10, 2023, with a chief complaint of fever, cough, and body aches, which began on March 5, 2023.

**Medical History:**

John has a history of mild asthma, for which he takes an as-needed bronchodilator. He is not known to have any significant medical conditions or allergies.

**Admission Findings:**

Upon admission, John's temperature was 38.5°C (101.3°F), blood pressure was 120/80 mmHg, pulse was 100 beats per minute, and oxygen saturation was 95% on room air. He had a cough, but no wheezing or rhonchi were audible. His chest x-ray showed interstitial infiltrates consistent with primary influenza pneumonia.

**Diagnostic Workup:**

A rapid antigen test was performed on March 10, 2023, and was negative. An RT-PCR test was ordered, and the results showed a positive diagnosis of influenza A (H3N2) on March 11, 2023.

**Treatment:**

Based on the patient's diagnosis and medical history, a treatment plan was developed. John was started on oseltamivir 75 mg orally twice a day, which was continued until March 14, 2023. He was also prescribed a cough suppressant and an antipyretic to manage his symptoms. As a precaution, due to his history of asthma, a bronchodilator was prescribed as needed.

**Hospital Course:**

John's fever resolved on March 12, 2023, and his symptoms began to improve. He was afebrile by March 14, 2023, and his oxygen saturation remained stable. His chest x-ray was repeated on March 14, 2023, and showed improvement in the interstitial infiltrates.

**Discharge Instructions:**

John was discharged on March 15, 2023, with the following instructions:

* Continue oseltamivir for another 2 days
* Use a bronchodilator as needed for cough and shortness of breath
* Monitor for signs of pneumonia, including fever, cough, and worsening shortness of breath
* Follow up with his primary care physician if symptoms worsen or do not improve

**Medications:**

* Oseltamivir 75 mg orally twice a day
* Cough suppressant as needed
* Antipyretic as needed
* Bronchodilator as needed

**Follow-up:**

John is scheduled to follow up with his primary care physician in 1 week to reassess his symptoms and ensure that he is recovering well from his illness.

**Conclusion:**

John Doe was successfully treated for influenza A (H3N2) with oseltamivir and supportive care. His symptoms resolved, and he was discharged home with instructions for follow-up and monitoring for any signs of pneumonia.